DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,000 | 0.0% | 627 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 627 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -85.7% | 627 | -85.8% | 0.00% | – |
| Q1 2016 | $14,000 | -30.0% | 4,427 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | -4.8% | 4,427 | 0.0% | 0.00% | – |
| Q3 2015 | $21,000 | -61.8% | 4,427 | -43.2% | 0.00% | – |
| Q2 2015 | $55,000 | +83.3% | 7,796 | +118.1% | 0.00% | – |
| Q1 2015 | $30,000 | +87.5% | 3,574 | +113.1% | 0.00% | – |
| Q4 2014 | $16,000 | +14.3% | 1,677 | +0.5% | 0.00% | – |
| Q3 2014 | $14,000 | -54.8% | 1,668 | -36.8% | 0.00% | – |
| Q2 2014 | $31,000 | -99.1% | 2,638 | -99.1% | 0.00% | -100.0% |
| Q1 2014 | $3,625,000 | – | 285,847 | +14292250.0% | 0.00% | – |
| Q4 2013 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |